Current status of heart transplantation in children: Update 2003

Pediatric Clinics of North America

Volumn 50, Issue 6, 2003, Pages 1375-1391

  Blume, Elizabeth D ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCINEURIN INHIBITOR; CALCITONIN; CALCIUM; CALCIUM ANTAGONIST; CYCLOSPORIN A; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPATITIS B VACCINE; HORMONE; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; MAGNESIUM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PNEUMOCOCCUS VACCINE; RAPAMYCIN; STATINE DERIVATIVE; STEROID; TACROLIMUS; VITAMIN D;

BONE MARROW SUPPRESSION; CARDIOVASCULAR DISEASE; CHILD; CHILD DEVELOPMENT; CHILD NUTRITION; CLINICAL TRIAL; CUSHINGOID SYNDROME; DIABETES MELLITUS; EXERCISE; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INTERPERSONAL COMMUNICATION; LONG TERM CARE; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OSTEOPOROSIS; PATIENT COMPLIANCE; PATIENT REFERRAL; PEDIATRICS; PRIMARY MEDICAL CARE; QUALITY OF LIFE; REVIEW; SOCIAL PSYCHOLOGY; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 0347626160     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(03)00151-2     Document Type: Review

References (79)

1. Kantrowitz A, Haller JD, Joos H, Cerruti MM, Carstensen HE. Transplantation of the heart in an infant and an adult. Am J Cardiol 1968;22:782-90.
2. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Mohacsi PJ, et al. The registry of the International Society for Heart and Lung Transplantation: fifth official pediatric report: 2001 to 2002. J Heart Lung Transplant 2002;21:827-40.
3. Fricker FJ, Addonizio L, Bernstein D, Boucek M, Boucek R, Canter C, et al. Heart transplantation in children: indications. Pediatr Transplant 1999;3:333-42.
4. Morrow WR, Naftel D, Chinnock R, Canter C, Boucek M, Zales V, et al. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. J Heart Lung Transplant 1997;16:1255-66.
5. Armitage JM, Fricker FJ, del Nido P, Starzl TE, Hardesty RL, Griffith BP. A decade (1982-1992) of pediatric cardiac transplantation and the impact of FK506 immunosuppression. J Thorac Cardiovasc Surg 1993;105:464-72.
6. Ward KM, Canter CE, Webber SA, Chin C, Pahl E. Anthracycline cardiomyopathy and pediatric heart transplantation [abstract]. J Heart Lung Transplant 2002;21:64.
7. Morgan E, Pahl E. Early heart transplantation in a child with advanced lymphoma. Pediatr Transplant 2002;6(6):509-12.
8. Jacobs ML, Blackstone EH, Bailey LL. Intermediate survival in neonates with aortic atresia: a multi-institutional study. J Thorac Cardiovasc Surg 1998;116:417-31.
9. Morrow WR, Naftel D, Chinnock R, Canter C, Boucek M, Zales V, et al. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. J Heart Lung Transplant 1997;16:1255-66.
10. Canter CE, Moorhead S, Huddleston CB, Spray TL. Restrictive atrial communication as a determinant of outcome of cardiac transplantation for hypoplastic left heart syndrome. Circulation 1993;88(II):456-60.
11. Vricella LA, Razzouk AJ, del Rio M, Gundry SR, Bailey LL. Heart transplant for hypoplastic left heart syndrome: modified technique for reducing circulatory arrest time. J Heart Lung Transplant 1998;17:1167-71.
12. Hosenpud JD, Pamidi SR, Fiol BS, Cinquegrani MP, Keck BM. Outcomes in patients who are hepatitis B surface antigen-positive before transplantation: an analysis and study using the joint ISHLT/UNOS thoracic registry. J Heart Lung Transplant 2000;19:781-5.
13. Bouthot BA, Murthy BV, Schmid CH, Levey AS, Pereira BJ. Longterm follow-up of hepatitis C virus infection among organ transplant recipients. Transplantation 1997;63:849-53.
14. United Network for Organ Shafing. OPTN/SRTR Annual Report 1991-2000. HHS/HRSA/OSP/DOT;UNOS;URREA. Richmond (VA): United Network for Organ Sharing; 2001.
15. Webber SA, Fricker FJ, Michael M, Pickering RM, del Nido PJ, Griffiths BP, et al. Orthotopic heart transplantation in children with congenital heart disease. Ann Thorac Surg 1994;58:1664-9.
16. Hsu DT, Quaegebeur JM, Michler RE, Smith CR, Rose EA, Kichuk MR, et al. Heart transplantation in children with congenital heart disease. J Am Coll Cardiol 1995;26:743-9.
17. Vricella LA, Razzouk AJ, Gundry SR, Larsen RL, Kuhn MA, Bailey LL. Heart transplantation in infants and children with situs inversus. J Thorac Cardiovasc Surg 1998;116:82-9.
18. Cooper M, Fuzesi L, Addonizio L, Hsu DT, Smith CR, Rose EA. Pediatric heart transplantation after operations involving the pulmonary arteries. J Thorac Cardiovasc Surg 1991;102:386-94.
19. Kirshman US, Hsu DT, Donnelly CM, Kichuk MR, Martin EC, Michler RE, et al. Management of aortopulmonary collaterals in children following heart transplantation for complex congenital heart disease [abstract]. J Heart Lung Transplant 1997;16:71.
20. Lamour JM, Hsu DT, Kichuk MR, Galantowicz ME, Quaegebeur JM, Addonizio LJ. Regression of pulmonary arteriovenous malformations following heart transplantation. Pediatr Transplant 2000;4:280-4.
21. Pigula FA, Gandhi S, Ristich J, Stukus D, McCurry K, Webber SA, et al. Cardiopulmonary transplantation for congenital heart disease in the adult. J Heart Lung Transplant 2001;20:297-303.
22. Del Nido PJ, Armitage JM, Fricker FJ, Shaver M, Cipriani L, Duyal G, et al. Extracorporeal membrane oxygenation support as a bridge to pediatric heart transplantation. Circulation 1994;90(2): 66-9.
23. Weyand M, Kececioglu D, Kehl HG. Neonatal mechanical bridging to total orthotopic heart transplantation. Ann Thorac Surg 1998;66:519-22.
24. Reinhartz O, Keith FM, El-Banayosy A, McBride LR, Robbins RC, Copeland JG, et al. Multicenter experience with the Thoratec ventricular assist device in children and adolescents. J Heart Lung Transplant 2001;20:439-48.
25. Helman DN, Addonizio LJ, Morales DLS, Catanese KA, Flannery MA, Quagebeur JM, et al. Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant. J Heart Lung Transplant 2000;16:121-6.
26. Rotondo K, Naftel D, Boucek R, Canter C, McGiffin D, Pahl E, et al. Allograft rejection following cardiac transplantation in infants and children: a multi-institutional study. J Heart Lung Transplant 1996;15:S80.
27. Kawauchi M, Gundry SR, de Begona JA, Fullerton DA, Razzouk AJ, Boucek MM, et al. Male donor into female recipient increases the risk of pediatric heart allograft rejection. Ann Thorac Surg 1993;55(3):716-8.
28. Mills RM, Naftel DC, Kirklin JK, Van Bakel AB, Jaski BE, Massin EK, et al. Heart transplant rejection with hemodynamic compromise: a multi-institutional study of the role of endomyocardial infiltrate. J Heart Lung Transplant 1997;16:813-21.
29. Pahl E, Naftel DC, Canter CE, Frazier EA, Kirklin JK, Morrow WR. Pediatric heart transplant study: death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients: a multi-institutional study. J Heart Lung Transplant 2001;20:279-87.
30. Webber SA, Naftel DC, Parker J, Mulla N, Balfour I, Kirklin JK, et al. Late rejection episodes greater than 1 year after pediatric heart transplantation: risk factors and outcomes. J Heart Lung Transplant 2003;22(8):869-75.
31. Chin C, Naftel DC, Singh TP, Blume ED, Luikart H, Bernstein D, et al. Risk factors for recurrent rejection in pediatric heart transplantation: a multicentered experience. J Heart Lung Transplant, in press.
32. Collins KK, Thiagarajan RR, Chin C, Dubin AM, Bernstein D, Robbins RC, et al. Atrial arrhythmias and conduction abnormalities in pediatric heart transplantation. J Heart Lung Transplant, in press.
33. Moran AM, Lipshulz S, Rifai N, O'Brien P, Mooney H, Lipsitz S, et al. Noninvasive assessment of rejection in pediatric heart transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection. J Heart Lung Transplant 2000;19(8):756-64.
34. Balzer DT, Moorhead S, Saffitz JE, Huddleston CB, Spray TL, Canter CE. Utility of surveillance biopsies in infant heart transplant recipients. J Heart Lung Transplant 1995;14:1095-101.
35. Hsu DT, Spotnitz HM. Echocardiographic diagnosis of cardiac allograft rejection. Prog Cardiovasc Dis 1990;33:149-60.
36. Boucek MM, Mathis CM, Boucek Jr RJ, Hodgkin DD, Kanakriyeh MS, McCormack J, et al. Prospective evaluation of echocardiography for primary rejection surveillance after infant heart transplantation: comparison with endomyocardial biopsy. J Heart Lung Transplant 1994;13(1 Pt 1): 66-73.
37. Loker J, Darragh R, Ensing G, Caldwell R. Echocardiographic analysis of rejection in the infant heart transplant recipient. J Heart Lung Transplant 1994;13:1014-8.
38. Holzmann G, Gidding SS, Crawford SE, Zales VR. Usefulness of left ventricular inflow Doppler in predicting rejection in pediatric cardiac transplant recipients. Am J Cardiol 1994;73:205-7.
39. Kimball TR, Semler DC, Witt SA, Khoury PR, Daniels SR. Noninvasive markers for acute heart transplant rejection in children with the use of automated border detection. J Am Soc Echocardiogr 1997;10:964-72.
40. Stempfle HU, Angermann CE, Kraml P, Schutz A, Kemkes BM, Theisen K. Serial changes during acute cardiac allograft rejection: quantitative ultrasound tissue analysis versus myocardial histologic findings. J Am Coll Cardiol 1993;22:310-7.
41. Kertesz NJ, Gajarski RJ, Towbin JA, Geva T. Effect of donor and recipient size mismatch in left ventricular remodeling after pediatric orthotopic heart transplantation. Am J Cardiol 1995;76:1167-72.
42. Santos-Ocampo SD, Sekarski TJ, Saffitz JE, Bridges ND, Huddleston CB, Spray TL, et al. Echocardiographic characteristics of biopsy proven cellular rejection in infant heart transplant recipients. J Heart Lung Transplant 1996;15:25-34.
43. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1990;119(3): 538-44.
44. Pahl E, Naftel D, Kuhn M, Shaddy R, Morrow WR, Kirklin J. The impact and outcome of transplant coronary disease in a pediatric population: a multi-institutional study [abstract]. Circulation, in press.
45. Pahl E, Zales VR, Fricker FJ, et al. Posttransplant coronary artery disease in children: a multicenter national survey. Circulation 1994;90(2):56-60.
46. Larsen RL, Applegate PM, Dyar DA, Ribeiro PA, Fritzsche SD, Mulla NF, et al. Dobutamine stress echocardiography for assessing coronary artery disease after transplantation in children. J Am Coll Cardiol 1998;32:515-20.
47. Pahl E, Crawford SE, Swenson JM, Duffy CE, Fricker FJ, Backer CL, et al. Dobutamine stress echocardiography: experience in pediatric heart transplant recipients. J Heart Lung Transplant 1999;18:725-32.
48. Kuhn MA, Jutzy KR, Deming DD, Cephus CE, Chinnock RE, Johnston J, et al. The medium-term findings in coronary arteries by intravascular ultrasound in infants and children after heart transplantation. J Am Coll Cardiol 2000;36:250-4.
49. Dent CL, Canter CE, Hirsch R, Balzer DT. Transplant coronary artery disease in pediatric heart transplant recipients. J Heart Lung Transplant 2000;19:240-8.
50. Morrow WR, Chinnock RE. Survival after heart transplantation. In: Tejani AH, Harmon WE, Fine RN, editors. Pediatric solid organ transplantation. Copenhagen: Munksgaard; 2000. p. 417-26.
51. Hruban RH, Gao SZ, Baldwin WM, Schroeder JS. Accelerated graft arterio-sclerosis. In: Baumgartner WA, Reitz B, Kasper E, Theodore J, editors. Heart and lung transplantation. Philadelphia: WB Saunders Company; 2002. p. 387-413.
52. Ikonen TS, Gummert JF, Serkova N, Hayase M, Honda Y, Kobayase Y, et al. Efficacies of sirolimus (rapamycin) and cyclosporine in allograft vascular disease in non-human primates trough levels of sirolimus correlate with inhibition of progression of arterial intimal thickening. Transpl Int 2000;13(Suppl 1):S314-20.
53. Kanter K, Pahl E, Naftel DC, Canter C, Webber S, Frazier E, et al. Pediatric heart transplant study group: preventing CMV infection in pediatric heart transplant recipients. Does prophylaxis work [abstract]. J Heart Lung Transplant 1998;17:59-60.
54. English RF, Pophal SA, Bacanu S, Fricker FJ, Boyle GJ, Miller SA, et al. Long-term comparison of tacrolimus and cyclosporine induced nephrotoxicity in pediatric heart transplant recipients. Am J Transplant 2002;2:769-73.
55. First MR, Gerber DA, Hariharan S, Kaufman DB, Shapiro R. Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation 2002;73:379-86.
56. Wagner K, Webber SA, Kurland G, Boyle GJ, Miller SA, Cipriani L, et al. New onset diabetes mellitus in pediatric thoracic organ recipients under tacrolimus based immunosuppression. J Heart Lung Transplant 1997;16:275-82.
57. Chin C, Rosenthal D, Bernstein D. Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients. Pediatr Transplant 2000;4:193-9.
58. Penson MG, Winter WE, Fricker FJ, Harker K, Kahler DA, Kubilis PS, et al. Tacrolimus-based triple drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients. J Heart Lung Transplant 1999;18:707-13.
59. Law YM, Yim R, Agatista PK, Boyle GJ, Miller SA, Lawrence K, et al. Lipid profiles in pediatric thoracic recipients are determined by the immunosuppressive regimens [abstract]. J Heart Lung Transplant 2002;21:172.
60. Boucek MM, Faro A, Novick RJ, Bennett LE, Keck BM, Hosenpud JD. The registry of the International Society for Heart and Lung Transplantation: fourth official pediatric report-2000. J Heart Lung Transplant 2001;20(1):39-52.
61. Chinnock R, Baum M. Somatic growth in infant heart transplant recipients. Pediatr Transplant 1998;2(1):30-4.
62. Ibrahim J, Canter CE, Chinnock RE, Kirklin JK, Naftel DC, Basile S, West L. Linear and somatic growth following pediatric heart transplantation. J Heart Lung Transplant 2002;21(1):63.
63. Baum M, Chinnock R, Ashwal S, Peverini R, Trimm F, Bailey L. Growth and neurodevelopmental outcome of infants undergoing heart transplantation. J Heart Lung Transplant 1993;12(6 Pt 2): S211-7.
64. Baum M, Freier K, Chinnock RE. Growth and cognitive development. In: Tejani AH, Harmon WE, Fine RN, editors. Pediatric solid organ transplantation. Copenhagen: Munksgaard; 2000. p. 433-9.
65. Kobashigawa JA, Leaf DA, Lee N, Gleeson MP, Liu H, Hamilton MA, et al. A controlled trial of exercise rehabilitation after heart transplantation: randomized controlled trial. N Engl J Med 1999;340(4):272-7.
66. Nixon PA, Fricker FJ, Noyes BE, Webber SA, Orenstein DM, Armitage JM. Exercise testing in pediatric heart and/or lung transplant recipients. Chest 1995;107:1328-35.
67. Hsu DT, Garofano RP, Douglas JM, Michler RE, Quaegebeur JM, Gersony WM, et al. Exercise performance after pediatric heart transplantation. Circulation 1993;88(II):238-42.
68. Uzark KC, Sauer SN, Lawrence KS, Miller J, Addonizio L, Crowley DC. The psychosocial impact of pediatric heart transplantation. J Heart Lung Transplant 1992;11:1160-7.
69. Wray J, Pot-Mees C, Zeitlin H, Radley-Smith R, Yacoub M. Cognitive function and behavioural status in pediatric heart and heart-lung transplant recipients: the Harefield experience. BMJ 1994;309:837-41.
70. Slater JA. Psychiatric aspects of organ transplantation in children and adolescents. Child Adolesc Psychiatr Clin N Am 1994;3:557-98.
71. DeMaso DR, Twente AW, Spratt EG, O'Brien P. The impact of psychological functioning, medical severity, and family functioning in pediatric heart transplantation. J Heart Lung Transplant 1995;14:1102-8.
72. Wray J, Yacoub MH. Psychosocial evaluation of children after heart and heart-lung transplantation. In: Kapoor AS, Laks H, Schroeder JS, Yacoub MH, editors. Cardiomyopathies and heart-lung transplantation. New York: McGraw-Hill; 1991. p. 447-60.
73. Wray J, Radley-Smith R, Yacoub M. Effect of cardiac or heart-lung transplantation on the quality of life of the paediatric patient. Qual Life Res 1992;1:41-6.
74. Todaro JF, Fennell EB, Sears SF, Rodrigue JR, Roche AK. Review: cognitive and psychological outcome of pediatric heart transplantation. J Pediatr Psychol 2000;25:567-76.
75. Wray J, Long T, Radley-Smith R, Yacoub M. Returning to school after heart or heart-lung transplantation: how well do children adjust? Transplantation 2001;72:100-6.
76. Nixon PA, Morris KA. Quality of life in pediatric heart, heart-lung, and lung transplant recipients. Int J Sports Med Suppl 2000;2:S109-11.
77. Ringewald JM, Gidding SS, Crawford SE, Backer CL, Mavroudis C, Pahl E. Nonadherence is associated with late rejection in pediatric heart transplant recipients. J Pediatr 2001;139:75-8.
78. Serrano-Ikkos E, Lask B, Whitehead B, Eisler I. Unsatisfactory adherence after pediatric heart and heart-lung transplantation. J Heart Lung Transplant 1998;17:1177-83.
79. Flippin MS, Canter CE, Balzer DT. Increased morbidity and high variability of cyclosporine levels in pediatric heart transplant recipients. J Heart Lung Transplant 2000;19(4):343-9.